Vertex Pharmaceuticals, Inc. - VRTX - stock price prediction, stock price target, analyst ratings from 34 analysts
Vertex Pharmaceuticals, Inc. has a share price target of US$ 497, revenue growth forecast of 8.6%, and profit growth estimate of 865.9% for FY25, based on top 34 analyst calls.
Upgrade Your Plan
You need to upgrade your subscription plan to access this feature